Todos os estudos
RecrutamentoFarmacologia Humana (Fase I) - OutrosIntervencionista

A Study to Learn How Different Forms of Study Medicine CTB-AVP Are Taken up Into the Blood and How It Is Taken up Into The Blood When Taken on An Empty Stomach or Taken With a Meal in Healthy Adults

This research study is about understanding how a new medication called CTB-AVP works in the body. Specifically, it's looking at how different forms of this medicine get absorbed into the bloodstream. Researchers also want to find out if taking the medicine with food or on an empty stomach changes how well it's absorbed. This information is important because CTB-AVP is being developed to treat serious infections of the bladder and kidneys, known as complicated urinary tract infections, including a type called pyelonephritis. By studying healthy adults first, scientists can learn important details about the medicine's behaviour before it's tested in people who are unwell. This helps ensure future trials are as safe and effective as possible.

Em resumo

Status
Recrutamento
Fase
Farmacologia Humana (Fase I) - Outros
Patrocinador
Pfizer Inc.
Meta de inscrição
12
Iniciar
10 Oct 2023

Sobre o que é este estudo?

This study is a very early stage of research, sometimes called a Phase I study. Doctors and scientists are trying to understand exactly how a new medicine, called CTB-AVP, behaves once it’s in the human body. They want to see how much of the medicine gets into the bloodstream and how quickly this happens. This information is really important because it helps them work out the best way to give the medicine in the future.

A key part of this study is looking at different versions (forms) of CTB-AVP and whether taking the medicine with a meal or on an empty stomach makes a difference. Sometimes, food can change how well a medicine is absorbed, making it work better or worse. By finding this out early, researchers can give clear instructions later on about how patients should take the medicine.

This new medicine is being developed to treat serious types of urinary tract infections (UTIs). These infections can affect the bladder and sometimes spread to the kidneys, which is called pyelonephritis. UTIs can be very painful and, if they become complicated, can be quite serious. Understanding CTB-AVP's behaviour in healthy people now will help ensure that if it goes on to treat patients with these infections, it will be given in the most effective way.

Pontos principais

  • This study helps understand how a new medicine for serious UTIs works in the body.
  • It's an early-stage study involving healthy adults.
  • Researchers want to see if food affects medicine absorption.
  • Your participation could help develop future treatments.
  • You'll be closely monitored by a medical team.

Quem pode ser elegível?

To join this study, people typically need to be healthy adults, usually 18 years old or older. The study is open to both men and women.

Being 'healthy' means that you don't have any major ongoing medical conditions that could interfere with how the study medicine works or make your participation unsafe. This usually involves a doctor checking your general health and medical history.

The research team will have a specific list of health checks and requirements to make sure the study is right and safe for you. They will go through these details carefully with you if you are interested in taking part.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. Você tem 18 anos ou mais?
  2. Are you generally healthy?
  3. Are you able to attend several clinic visits?
  4. Você se sente confortável com exames de sangue?
  5. Are you prepared to follow specific instructions on taking medicine with or without food?
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

If you decide to take part, you would receive the study medicine, CTB-AVP. You would likely visit a clinic or research unit multiple times. During these visits, the research team would monitor your health and take blood samples at specific times to measure how the medicine is absorbed and leaves your body. You might also be asked to take the medicine in different ways, such as on an empty stomach or after a meal, so researchers can compare the effects. The total duration of your involvement could vary, but Phase I studies often involve a series of visits over a few weeks or months, with follow-up checks.

Riscos e benefícios potenciais

There is no direct personal health benefit for people participating in this study as they are healthy volunteers, but your contribution helps scientists understand this new medicine, which could eventually help patients with serious infections. As with all medicines, there's always a possibility of side effects, which the research team will explain in detail. You will be closely monitored for any reactions. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Localizações (1)

Algumas localizações dos sites são aproximadas. Estamos melhorando isso — por favor, verifique com a equipe de teste antes de viajar.
  • —
    Não verificado
    Bélgica

Perguntas frequentes

What is a 'Phase I' study?

It's an early stage of human testing where researchers mainly focus on how safe a new medicine is and how it behaves in the body, often involving healthy volunteers.

Why are healthy people in a study for an infection medicine?

Studying healthy people helps researchers understand the basic movements of the medicine in the body without other illnesses complicating the results. This makes future testing safer and more effective for patients.

What is a 'complicated urinary tract infection'?

This is a serious bladder or kidney infection that might need more specific treatment, sometimes because of other health problems or if it involves the kidneys (pyelonephritis).

Will I know if I'm getting the 'different forms' of the medicine?

The research staff will explain exactly what you will be given and when, including any variations in the medicine or instructions about food.

Tenho que pagar para participar do estudo?

No, you do not have to pay to participate in a clinical trial. Any study-related costs are covered by the research team.

Como saber mais

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "A Study to Learn How Different Forms of Study Medicine CTB-A…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.